1. Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement;Eslam;Lancet Gastroenterol. Hepatol.,2021
2. Pioglitazone ameliorates nonalcoholic steatohepatitis by down-regulating hepatic nuclear factor-kappa B and cyclooxygenases-2 expression in rats;Zhao;Chin. Med. J.,2012
3. Celecoxib ameliorates non-alcoholic steatohepatitis in type 2 diabetic rats via suppression of the non-canonical Wnt signaling pathway expression;Feng;PLoS One,2014
4. Discovery of small molecule acting as multitarget inhibitor of colorectal cancer by simultaneous blocking of the key COX-2, 5-LOX and PIM-1 kinase enzymes;El-Miligy;Bioorg. Chem.,2021
5. Celecoxib for stage III colon cancer;Kerr;JAMA,2021